Usefulness of pindolol in neurocardiogenic syncope

Demosthenes Iskos, John Dutton, Melvin M. Scheinman, Keith G. Lurie

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


We prospectively studied the efficacy of pindolol, a β-adrenergic blocker with intrinsic sympathomimetic activity (ISA), for the prevention of syncope recurrences in 31 patients with recurrent neurocardiogenic syncope. Pindolol proved to be an effective treatment, even in patients who had previously failed treatment with conventional β blockers, suggesting a clinical benefit from addition of ISA to β blockade in this setting.

Original languageEnglish (US)
Pages (from-to)1121-1124
Number of pages4
JournalAmerican Journal of Cardiology
Issue number9
StatePublished - 1998

Bibliographical note

Copyright 2017 Elsevier B.V., All rights reserved.


Dive into the research topics of 'Usefulness of pindolol in neurocardiogenic syncope'. Together they form a unique fingerprint.

Cite this